• Home >
  • Health Library >
  • Compendium of Research >
  • A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study

Yoo DH, Racewicz A, Brzezicki J, Yatsyshyn R, Baranauskaite A, Abud-Mendoza C, Navarra S, Kadinov V, Sariego IG, Hong SS, Lee SY, Park W, Arteaga ET

https://www.ncbi.nlm.nih.gov/pubmed/27038608

Arthritis Res Ther. 2016 Apr 2;18:82. doi: 10.1186/s13075-016-0981-6

PMID:27038608PMCID:PMC4818886DOI:10.1186/s13075-016-0981-6